Search results
Psoriatic Arthritis Drugs Comparably Improve Joint Outcomes
Medscape· 6 days agoReal-world study data suggest there is little difference among five drug classes commonly used to...
If You Invested $1000 in AbbVie a Decade Ago, This is How Much It'd Be Worth Now
Zacks via Yahoo Finance· 10 hours agoAbbVie enjoys leadership positions in key therapeutic areas including immunology, hematologic...
Izokibep Enthesitis Benefit Lacking in Phase 2b/3 PsA Trial
Medscape· 6 days agoThe primary efficacy endpoint was met, but the novel small molecule therapeutic did not reduce...
Psoriasis study shows high level of arthritis symptoms in patients
Medical Xpress· 6 days agoThe 25% figure confirms existing knowledge that up to a third will go on to develop psoriatic ...
Amgen Inc. (NASDAQ:AMGN) Stake Lowered by First PREMIER Bank
ETF DAILY NEWS· 7 hours agoFirst PREMIER Bank reduced its stake in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 1.1% during the 1st quarter, according to the company in its most recent filing with the Securities ...
J&J (JNJ) Seeks Expanded Use of Tremfya for Crohn's Disease
Zacks via Yahoo Finance· 3 days agoJ&J (JNJ) seeks label expansion for Tremfya for treating moderately to severely active Crohn's...
Lane & Associates LLC Buys 1,289 Shares of Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 5 hours agoLane & Associates LLC grew its stake in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 45.2% during the first quarter, according to the company in its most recent disclosure with the ...
First PREMIER Bank Lowers Stake in Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 5 hours agoFirst PREMIER Bank lowered its position in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 3.9% during the first quarter, according to the company in its most recent Form 13F filing ...
States struggle to help patients navigate insurance hurdle known as ‘step therapy’
North Dakota Monitor via Yahoo News· 2 days agoCassidy Yermal, 32, began experiencing debilitating migraines when she was 17 years old. As a...
FDA Approves Skyrizi for Ulcerative Colitis
Medscape· 6 days agoThe approval is the fourth indication for the anti–interleukin 23 monoclonal antibody after approval for Crohn's disease, psoriatic arthritis, and plaque...